Cargando…
Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study
Anti-inflammatory drugs such as corticosteroids may beneficially modulate the host inflammatory response to coronavirus disease 2019 (COVID-19) pneumonia. The aim of this study was to evaluate the impact of addition of corticosteroids to the hospital protocol for treatment of suspected or confirmed...
Autores principales: | Bani-Sadr, Firouzé, Hentzien, Maxime, Pascard, Madeline, N'Guyen, Yohan, Servettaz, Amélie, Andreoletti, Laurent, Kanagaratnam, Lukshe, Jolly, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342082/ https://www.ncbi.nlm.nih.gov/pubmed/32634602 http://dx.doi.org/10.1016/j.ijantimicag.2020.106077 |
Ejemplares similares
-
Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection
por: Romaru, Juliette, et al.
Publicado: (2021) -
Does Copper Prevent Nosocomial Transmission of COVID-19?
por: Coutureau, Claire, et al.
Publicado: (2021) -
Two case reports of pyoderma gangrenosum and systemic lupus erythematosus: A rare but nonfortuitous association?
por: Lebrun, Delphine, et al.
Publicado: (2018) -
Association between Heparin Dose and 6-Week Mortality in Patients with COVID-19
por: Coutureau, Claire, et al.
Publicado: (2022) -
Early plasma interferon‐β levels as a predictive marker of COVID‐19 severe clinical events in adult patients
por: Berri, Fatma, et al.
Publicado: (2022)